BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31199431)

  • 1. ISAba1-dependent overexpression of eptA in clinical strains of Acinetobacter baumannii resistant to colistin.
    Potron A; Vuillemenot JB; Puja H; Triponney P; Bour M; Valot B; Amara M; Cavalié L; Bernard C; Parmeland L; Reibel F; Larrouy-Maumus G; Dortet L; Bonnin RA; Plésiat P
    J Antimicrob Chemother; 2019 Sep; 74(9):2544-2550. PubMed ID: 31199431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.
    Gerson S; Lucaßen K; Wille J; Nodari CS; Stefanik D; Nowak J; Wille T; Betts JW; Roca I; Vila J; Cisneros JM; Seifert H; Higgins PG
    Int J Antimicrob Agents; 2020 Mar; 55(3):105862. PubMed ID: 31837449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Novel
    Gerson S; Betts JW; Lucaßen K; Nodari CS; Wille J; Josten M; Göttig S; Nowak J; Stefanik D; Roca I; Vila J; Cisneros JM; La Ragione RM; Seifert H; Higgins PG
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
    Haeili M; Kafshdouz M; Feizabadi MM
    Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant
    Vijayakumar S; Swetha RG; Bakthavatchalam YD; Vasudevan K; Abirami Shankar B; Kirubananthan A; Walia K; Ramaiah S; Biswas I; Veeraraghavan B; Anbarasu A
    Microbiol Spectr; 2024 Feb; 12(2):e0251123. PubMed ID: 38214512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
    Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
    J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Nodari CS; Fuchs SA; Xanthopoulou K; Cayô R; Seifert H; Gales AC; Dilthey A; Higgins PG
    mSphere; 2021 Dec; 6(6):e0074621. PubMed ID: 34851165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii.
    Charretier Y; Diene SM; Baud D; Chatellier S; Santiago-Allexant E; van Belkum A; Guigon G; Schrenzel J
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
    Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS.
    Deveson Lucas D; Crane B; Wright A; Han ML; Moffatt J; Bulach D; Gladman SL; Powell D; Aranda J; Seemann T; Machado D; Pacheco T; Marques T; Viveiros M; Nation R; Li J; Harper M; Boyce JD
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoters of Colistin Resistance in
    Nurtop E; Bayındır Bilman F; Menekse S; Kurt Azap O; Gönen M; Ergonul O; Can F
    Microb Drug Resist; 2019 Sep; 25(7):997-1002. PubMed ID: 30964377
    [No Abstract]   [Full Text] [Related]  

  • 13. PmrB mutations including a novel 10-amino acid repeat sequence insertion associated with low-level colistin resistance in carbapenem-resistant Acinetobacter baumannii.
    Lunha K; Thet KT; Ngudsuntia A; Charoensri N; Lulitanond A; Tavichakorntrakool R; Wonglakorn L; Faksri K; Chanawong A
    Infect Genet Evol; 2020 Nov; 85():104577. PubMed ID: 33007498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-genome sequencing for the characterization of resistance mechanisms and epidemiology of colistin-resistant Acinetobacter baumannii.
    Hahm C; Chung HS; Lee M
    PLoS One; 2022; 17(3):e0264335. PubMed ID: 35245298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii.
    Boinett CJ; Cain AK; Hawkey J; Do Hoang NT; Khanh NNT; Thanh DP; Dordel J; Campbell JI; Lan NPH; Mayho M; Langridge GC; Hadfield J; Chau NVV; Thwaites GE; Parkhill J; Thomson NR; Holt KE; Baker S
    Microb Genom; 2019 Feb; 5(2):. PubMed ID: 30720421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.
    Beceiro A; Llobet E; Aranda J; Bengoechea JA; Doumith M; Hornsey M; Dhanji H; Chart H; Bou G; Livermore DM; Woodford N
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3370-9. PubMed ID: 21576434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic analysis of colistin-susceptible and colistin-resistant isolates identifies genes associated with colistin resistance in Acinetobacter baumannii.
    Park YK; Lee JY; Ko KS
    Clin Microbiol Infect; 2015 Aug; 21(8):765.e1-7. PubMed ID: 25911992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii.
    Pournaras S; Poulou A; Dafopoulou K; Chabane YN; Kristo I; Makris D; Hardouin J; Cosette P; Tsakris A; Dé E
    Antimicrob Agents Chemother; 2014; 58(2):828-32. PubMed ID: 24247145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of Tn6018-3' CS regions increases colistin MICs against Acinetobacter baumannii isolates harboring new variants of AbaRs.
    Savari M; Ekrami A; Shoja S; Bahador A
    Folia Microbiol (Praha); 2017 Sep; 62(5):373-379. PubMed ID: 28238067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.